$QBTS
D-Wave Quantum Inc. Stock $qbts

$qbts Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000190798224000049 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$2.465M	$2.906M	$8.758M
YoY Change	55.72%	21.34%	22.1%
Cost Of Revenue	$806.0K	$939.0K	$4.136M
YoY Change	-30.64%	-11.83%	41.5%
Gross Profit	$1.659M	$1.967M	$4.622M
YoY Change	294.06%	47.89%	8.75%
Gross Profit Margin	67.3%	67.69%	52.77%
Selling, General & Admin	$10.65M	$10.55M	$47.29M
YoY Change	-24.98%	-12.49%	49.62%
% of Gross Profit	641.95%	536.5%	1023.15%
Research & Development	$8.525M	$7.956M	$37.88M
YoY Change	-21.9%	-22.77%	18.0%
% of Gross Profit	513.86%	404.47%	819.52%
Depreciation & Amortization	$229.0K	$224.0K	$1.054M
YoY Change	-32.45%	-41.82%	-25.93%
% of Gross Profit	13.8%	11.39%	22.8%
Operating Expenses	$19.18M	$18.51M	$85.17M
YoY Change	-23.64%	-17.23%	33.68%
Operating Profit	-$17.52M	-$16.54M	-$80.55M
YoY Change	-29.06%	-21.34%	35.47%
Interest Expense	$1.719M	$1.785M	-$37.00K
YoY Change	278.63%	-78.23%	-100.8%
% of Operating Profit
Other Income/Expense, Net	$204.0K	-$1.257M	-$2.132M
YoY Change	148.78%	-2956.82%	-126.89%
Pretax Income	-$17.31M	-$16.01M	-$82.72M
YoY Change	-29.65%	25.22%	60.52%
Income Tax
% Of Pretax Income
Net Earnings	-$17.30M	-$16.01M	-$82.72M
YoY Change	-29.67%	25.22%	60.61%
Net Earnings / Revenue	-701.83%	-551.07%	-944.45%
Basic Earnings Per Share	-$0.11		-$0.60
Diluted Earnings Per Share	-$0.11	-$0.10	-$0.60
COMMON SHARES
Basic Shares Outstanding	116.8M shares	113.4M shares	138.0M shares
Diluted Shares Outstanding	161.3M shares		138.0M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.30M	$41.31M	$41.31M
YoY Change	203.78%	484.67%	484.67%
Cash & Equivalents	$27.30M	$41.31M
Short-Term Investments
Other Short-Term Assets	$2.569M	$1.923M	$1.923M
YoY Change	-8.71%	-47.21%	-47.21%
Inventory	$2.079M	$2.078M	$2.078M
Prepaid Expenses
Receivables	$1.735M	$1.652M	$1.652M
Other Receivables	$0.00	$86.00K	$86.00K
Total Short-Term Assets	$33.69M	$47.05M	$47.05M
YoY Change	125.91%	237.85%	237.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.909M	$10.77M	$10.77M
YoY Change	42.53%	369.66%	-5.71%
Goodwill
YoY Change
Intangibles	$302.0K	$179.0K
YoY Change	32.46%	-26.64%
Long-Term Investments	$2.574M		$1.168M
YoY Change			0.0%
Other Assets	$3.828M	$1.357M	$189.0K
YoY Change	183.35%	0.44%	3.28%
Total Long-Term Assets	$14.92M	$12.31M	$12.31M
YoY Change	18.9%	-5.47%	-5.47%
TOTAL ASSETS
Total Short-Term Assets	$33.69M	$47.05M	$47.05M
Total Long-Term Assets	$14.92M	$12.31M	$12.31M
Total Assets	$48.61M	$59.36M	$59.36M
YoY Change	77.01%	120.27%	120.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.037M	$6.808M	$6.808M
YoY Change	-87.15%	9.54%	9.54%
Accrued Expenses	$6.007M	$6.672M	$6.672M
YoY Change	-39.07%	-0.22%	16.72%
Deferred Revenue	$1.999M	$2.669M
YoY Change	9.41%	49.86%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$369.0K	$399.0K	$399.0K
YoY Change	-53.29%	-76.12%	-76.12%
Total Short-Term Liabilities	$10.86M	$11.25M	$11.25M
YoY Change	-39.95%	-29.01%	-29.01%
LONG-TERM LIABILITIES
Long-Term Debt	$63.04M	$63.85M	$63.85M
YoY Change	663.23%	717.44%	717.44%
Other Long-Term Liabilities	$11.66M	$8.737M	$8.737M
YoY Change	38.34%		-5.05%
Total Long-Term Liabilities	$63.04M	$72.59M	$72.59M
YoY Change	663.23%	829.29%	326.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.86M	$11.25M	$11.25M
Total Long-Term Liabilities	$63.04M	$72.59M	$72.59M
Total Liabilities	$85.56M	$83.84M	$83.84M
YoY Change	146.07%	155.13%	155.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$500.4M	-$483.1M
YoY Change	24.66%	28.21%
Common Stock	$16.00K	$16.00K
YoY Change	33.33%	45.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$36.96M	-$24.48M	-$24.48M
YoY Change
Total Liabilities & Shareholders Equity	$48.61M	$59.36M	$59.36M
YoY Change	77.01%	120.27%	120.27%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$17.30M	-$16.01M	-$82.72M
YoY Change	-29.67%	25.22%	60.61%
Depreciation, Depletion And Amortization	$229.0K	$224.0K	$1.054M
YoY Change	-32.45%	-41.82%	-25.93%
Cash From Operating Activities	-$12.10M	-$14.74M	-$60.65M
YoY Change	-11.03%	35.38%	34.18%
INVESTING ACTIVITIES
Capital Expenditures	$305.0K	$450.0K	$630.0K
YoY Change	376.56%	147.25%	48.94%
Acquisitions
YoY Change
Other Investing Activities	-$813.0K
YoY Change
Cash From Investing Activities	-$1.205M	-$450.0K	-$630.0K
YoY Change	1485.53%	147.25%	26.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.388M
YoY Change			-94.03%
Debt Paid & Issued, Net	$0.00		$1.465M
YoY Change	-100.0%		-93.19%
Cash From Financing Activities	-$726.0K	3.226M	95.64M
YoY Change	-104.66%	-24.94%	121.05%
NET CHANGE
Cash From Operating Activities	-$12.10M	-14.74M	-60.65M
Cash From Investing Activities	-$1.205M	-450.0K	-630.0K
Cash From Financing Activities	-$726.0K	3.226M	95.64M
Net Change In Cash	-$14.00M	-11.96M	34.36M
YoY Change	-828.19%	76.68%	-1520.89%
FREE CASH FLOW
Cash From Operating Activities	-$12.10M	-$14.74M	-$60.65M
Capital Expenditures	$305.0K	$450.0K	$630.0K
Free Cash Flow	-$12.41M	-$15.19M	-$61.28M
YoY Change	-9.21%	37.22%	34.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94303
CY2023	dei	City Area Code CityAreaCode	604
CY2023	dei	Local Phone Number LocalPhoneNumber	630-1428
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	583000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	423000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	47000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-630000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-498000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001907982
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41468
CY2023	dei	Entity Registrant Name EntityRegistrantName	D-Wave Quantum Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-1068854
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2650 East Bayshore Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Palo Alto
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	125882188	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	116792838	shares
CY2023	dei	Auditor Name AuditorName	Grant Thornton LLP
CY2023	dei	Auditor Location AuditorLocation	Bellevue, Washington
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2022	dei	Auditor Firm AuditorFirmId	271
CY2023Q4	us-gaap	Cash Cash	41307000	usd
CY2022Q4	us-gaap	Cash Cash	7065000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1652000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	757000	usd
CY2023Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	0	usd
CY2022Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	264000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2078000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2196000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2009000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3643000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	47046000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13925000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2551000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8223000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9133000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	179000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1357000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2023Q4	us-gaap	Assets Assets	59356000	usd
CY2022Q4	us-gaap	Assets Assets	26947000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1465000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3756000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5343000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6687000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1374000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1533000	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	399000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1863000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2669000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	420000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11250000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16040000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1630000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1892000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7028000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7301000	usd
CY2023Q4	qbts	Long Term Debt Noncurrent Fair Value LongTermDebtNoncurrentFairValue	31400000	usd
CY2022Q4	qbts	Long Term Debt Noncurrent Fair Value LongTermDebtNoncurrentFairValue	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	63850000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31168000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	79000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	83837000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	56410000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	161113744	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	161113744	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113335530	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113335530	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	469081000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381274000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-483061000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-400346000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10517000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10402000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24481000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29463000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59356000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26947000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8758000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	4136000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2923000	usd
CY2023	us-gaap	Gross Profit GrossProfit	4622000	usd
CY2022	us-gaap	Gross Profit GrossProfit	4250000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37878000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32101000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37014000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21539000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10068000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-80546000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	37000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	2335000	usd
CY2023	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	-640000	usd
CY2022	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	0	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2118000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-262000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6173000	usd
CY2023	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	0	usd
CY2022	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	629000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-916000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2547000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2169000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5756000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-82715000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53702000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137993736	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	137993736	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119647777	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119647777	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-82715000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53702000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	41000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-82830000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53661000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-18356000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2022	qbts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-16242000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1077000	usd
CY2022	qbts	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	959000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9164000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	41000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53702000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29463000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1898000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21919000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	416000	usd
CY2023	qbts	Adjustments To Additional Paid In Capital Short Swing Profit Settlement AdjustmentsToAdditionalPaidInCapitalShortSwingProfitSettlement	244000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-115000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-82715000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24481000	usd
CY2022Q3	qbts	Reverse Recapitalization Conversion Ratio ReverseRecapitalizationConversionRatio	0.889657
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-82715000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53702000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1054000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1423000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	21919000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	9164000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	791000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	910000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	32000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	66000	usd
CY2023	qbts	Noncash Interest Expense Income NoncashInterestExpenseIncome	-78000	usd
CY2022	qbts	Noncash Interest Expense Income NoncashInterestExpenseIncome	185000	usd
CY2023	qbts	Debt Instrument Noncash Interest And Final Payment Fee DebtInstrumentNoncashInterestAndFinalPaymentFee	0	usd
CY2022	qbts	Debt Instrument Noncash Interest And Final Payment Fee DebtInstrumentNoncashInterestAndFinalPaymentFee	1808000	usd
CY2023	qbts	Debt Instrument Noncash Amortization Of Commitment Fee DebtInstrumentNoncashAmortizationOfCommitmentFee	0	usd
CY2022	qbts	Debt Instrument Noncash Amortization Of Commitment Fee DebtInstrumentNoncashAmortizationOfCommitmentFee	175000	usd
CY2023	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	0	usd
CY2022	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	629000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-262000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6173000	usd
CY2023	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	-640000	usd
CY2022	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	0	usd
CY2023	qbts	Amortization Of Debt Issuance Costs Net AmortizationOfDebtIssuanceCostsNet	993000	usd
CY2022	qbts	Amortization Of Debt Issuance Costs Net AmortizationOfDebtIssuanceCostsNet	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-955000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2459000	usd
CY2023	qbts	Gain Loss On Share Issuance Under Equity Line Of Credit GainLossOnShareIssuanceUnderEquityLineOfCredit	0	usd
CY2022	qbts	Gain Loss On Share Issuance Under Equity Line Of Credit GainLossOnShareIssuanceUnderEquityLineOfCredit	-75000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	818000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	337000	usd
CY2023	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	-264000	usd
CY2022	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	-1332000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	237000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	148000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1636000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	387000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2614000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3597000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1374000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	715000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	958000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-929000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-510000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-821000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60649000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45226000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	75000	usd
CY2023	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	0	usd
CY2022	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	4100000	usd
CY2023	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2022	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	6528000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	924000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1897000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1077000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	491000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	416000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	244000	usd
CY2022	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	29007000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20000000	usd
CY2023	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	2996000	usd
CY2022	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	3159000	usd
CY2023	qbts	Repayments Of Government Assistance RepaymentsOfGovernmentAssistance	374000	usd
CY2022	qbts	Repayments Of Government Assistance RepaymentsOfGovernmentAssistance	398000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	420000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1465000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	21511000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1808000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95636000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43265000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-115000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34242000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2418000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9483000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41307000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2023	qbts	Transfer From Inventory To Property Plant And Equipment TransferFromInventoryToPropertyPlantAndEquipment	323000	usd
CY2022	qbts	Transfer From Inventory To Property Plant And Equipment TransferFromInventoryToPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	88000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	360000	usd
CY2023	qbts	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Resolution Of Contingency RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityResolutionOfContingency	0	usd
CY2022	qbts	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Resolution Of Contingency RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityResolutionOfContingency	1113000	usd
CY2023	qbts	Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable	310000	usd
CY2022	qbts	Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable	66000	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	420000	usd
CY2023	qbts	Warrants Issued WarrantsIssued	0	usd
CY2022	qbts	Warrants Issued WarrantsIssued	8100000	usd
CY2023	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	0	usd
CY2022	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	5294000	usd
CY2023	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	0	usd
CY2022	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	2893000	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	3271000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	189871000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. DESCRIPTION OF BUSINESS</span></div><div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger” to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company specializes in commercializing annealing quantum computing systems and offers real-time quantum computing as a service (QCaaS) available in 39 countries. The Company possess deep scientific and technical capabilities in hardware and software, enabling it to support business applications at production scale. For the year ended December 31, 2023, approximately 70 percent of the Company's revenue comes from commercial customers across various industries such as financial services, manufacturing, automotive, pharmaceutical, information technology, retail, and professional services.</span></div>
CY2023Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	39	country
CY2023Q4	qbts	Number Of Board Members NumberOfBoardMembers	7	board_member
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-483100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-82700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53700000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45200000	usd
CY2023Q4	us-gaap	Cash Cash	41300000	usd
CY2023Q4	qbts	Working Capital Deficit WorkingCapitalDeficit	-35800000	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	-24500000	usd
CY2022Q3	qbts	Cash Acquired Through Reverse Recapitalization And Proceeds From Issuance Of Private Placement CashAcquiredThroughReverseRecapitalizationAndProceedsFromIssuanceOfPrivatePlacement	49000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2022Q3	qbts	Payments Of Reverse Capitalization Transaction Costs Including Costs Paid On Behalf Of Related Party PaymentsOfReverseCapitalizationTransactionCostsIncludingCostsPaidOnBehalfOfRelatedParty	14200000	usd
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	qbts	Equity Line Of Credit Ownership Restriction Percentage EquityLineOfCreditOwnershipRestrictionPercentage	0.099
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	63700000	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	42147838	shares
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes as of the date of the consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to hours estimated to complete the remaining performance obligations, (ii) fair value of financial instruments, and (iii) long term revenue forecasts used in the accounting for the SIF Loan (see Note 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, increased interest rates, Ukraine/Russia conflict, the Israel-Hamas War, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2023Q4	qbts	Class Of Warrant Or Right Cap On Issuable Number Of Shares Ratio ClassOfWarrantOrRightCapOnIssuableNumberOfSharesRatio	0.361
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1000000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	2400000	usd
CY2023Q4	qbts	Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent	644000	usd
CY2022Q4	qbts	Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent	757000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1008000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	58000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2669000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2023	us-gaap	Advertising Expense AdvertisingExpense	300000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	800000	usd
CY2022	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	100000	usd
CY2023	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	0	usd
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Class Of Warrant Or Right Restriction Period ClassOfWarrantOrRightRestrictionPeriod	P30D
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000.0	usd
CY2022Q3	qbts	Commitment Fee Liability CommitmentFeeLiability	2600000	usd
CY2022Q3	qbts	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18700000	usd
CY2022Q3	qbts	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	9130000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000	usd
CY2022Q3	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	16378000	usd
CY2022Q3	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	14017000	usd
CY2022Q3	qbts	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18735000	usd
CY2022Q3	qbts	Reverse Recapitalization Liabilities Assumed ReverseRecapitalizationLiabilitiesAssumed	16378000	usd
CY2022Q3	qbts	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	2459000	usd
CY2022Q3	qbts	Reverse Recapitalization Net ReverseRecapitalizationNet	37572000	usd
CY2022Q3	qbts	Stock Issued During Period Shares New Issues And Reverse Recapitalization StockIssuedDuringPeriodSharesNewIssuesAndReverseRecapitalization	10144040	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110007972	shares
CY2022Q3	qbts	Common Stock Cumulative Shares Forfeited CommonStockCumulativeSharesForfeited	4484425	shares
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8758000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8758000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	79000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2023Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	2793000	usd
CY2022Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	1835000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1790000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2719000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2719000	usd
CY2023	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	7089000	usd
CY2022	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	5325000	usd
CY2023	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	6131000	usd
CY2022	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	6254000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2748000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.73
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3Y
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2052000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2170000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	26000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	26000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2078000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2196000	usd
CY2023Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	0	usd
CY2022Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	2459000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1092000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1858000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2581000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1641000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	961000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233000	usd
CY2023Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	664000	usd
CY2022Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	451000	usd
CY2023Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5343000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6687000	usd
CY2023Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	386000	usd
CY2022Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	391000	usd
CY2023Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	543000	usd
CY2022Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	559000	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	150000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	96000	usd
CY2023Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	64000	usd
CY2022Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	268000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	272000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89000	usd
CY2023Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	36000	usd
CY2022Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	1449000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	0	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	58000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	18000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	36000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	86000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2009000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3643000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	1168000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1168000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	189000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	183000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1357000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2023Q4	qbts	Equity Line Of Credit Right To Sell Common Stock Maximum Amount EquityLineOfCreditRightToSellCommonStockMaximumAmount	50000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26604000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25405000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24053000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23111000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2551000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2023	us-gaap	Depreciation Depreciation	900000	usd
CY2022	us-gaap	Depreciation Depreciation	1300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1245000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1197000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1066000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	953000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	179000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	244000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	399000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1863000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	63850000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31168000	usd
CY2023Q4	qbts	Long Term Debt Noncurrent Amortized Cost LongTermDebtNoncurrentAmortizedCost	32450000	usd
CY2022Q4	qbts	Long Term Debt Noncurrent Amortized Cost LongTermDebtNoncurrentAmortizedCost	31168000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	63850000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31168000	usd
CY2023Q4	qbts	Equity Line Of Credit Right To Sell Common Stock Maximum Amount EquityLineOfCreditRightToSellCommonStockMaximumAmount	50000000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1675000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1766000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	416000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	263000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	125000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	260000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.095
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.170
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1374000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1187000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1219000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1251000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1281000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6778000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13090000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4688000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8402000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-42502000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11214000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-40213000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-42488000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-82715000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-53702000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	54625000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	55430000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	15468000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13304000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	33321000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	30064000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	6349000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5943000	usd
CY2023Q4	qbts	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	873000	usd
CY2022Q4	qbts	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	978000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	498000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	547000	usd
CY2023Q4	qbts	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	0	usd
CY2022Q4	qbts	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	81000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	654000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	888000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	111788000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	107235000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	110981000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106919000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	807000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	316000	usd
CY2023Q4	qbts	Deferred Tax Liabilities Convertible Notes DeferredTaxLiabilitiesConvertibleNotes	0	usd
CY2022Q4	qbts	Deferred Tax Liabilities Convertible Notes DeferredTaxLiabilitiesConvertibleNotes	1000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	315000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	315000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	492000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	807000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	316000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.03
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.05
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.16
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.06
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.03
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2023	qbts	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.02
CY2022	qbts	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.23
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.05
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916609	shares
CY2023Q4	qbts	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prior To Exchange Ratio ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPriorToExchangeRatio	11.50
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.91
CY2023Q4	qbts	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.10
CY2023	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2023	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdTradingDays	20	day
CY2023	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdConsecutiveTradingDays	P30D
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2023	qbts	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2023	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1155713	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1155713	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	22767361	shares
CY2023	qbts	Share Based Compensation Arrangement By Share Based Payment Award Period Over Which Shares Reserved For Issuance Increases ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOverWhichSharesReservedForIssuanceIncreases	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.05
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16336134	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	80179000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1500081	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.07
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1380609	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1981000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1050228	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	17832	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.81
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15387546	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8763000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2337364	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.91
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1723000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1585735	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.88
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11464447	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.64
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10014807	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.33
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M20D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1449640	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.79
CY2023	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P7Y10M13D
CY2023Q4	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11464447	shares
CY2023Q4	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options To Be Issued Upon Exercise ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssuedUponExercise	9383963	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.11
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1486279	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3800000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P9Y9M21D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P9Y29D
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21919000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9164000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	22800000	usd
CY2023	qbts	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.027
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82715000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-82715000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-53702000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53702000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	137993736	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137993736	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119647777	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119647777	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44555218	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	42632045	shares
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000.0	usd
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock Period EquityLineOfCreditRightToSellCommonStockPeriod	P36M
CY2023Q4	qbts	Equity Line Of Credit Proceeds From Share Issuance Cumulative EquityLineOfCreditProceedsFromShareIssuanceCumulative	67900000	usd
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	161113744	shares
CY2023	qbts	Common Stock Exchange Ratio CommonStockExchangeRatio	1
CY2023Q4	qbts	Common Shares Voting Rights Votes CommonSharesVotingRightsVotes	1	vote
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	10774000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11427000	usd

Files In Submission

Name	View Source	Status
0001907982-24-000049-index-headers.html	Edgar Link	pending
R31.htm	Edgar Link	pending
0001907982-24-000049-index.html	Edgar Link	pending
0001907982-24-000049.txt	Edgar Link	pending
0001907982-24-000049-xbrl.zip	Edgar Link	pending
exhibit1063-limitedwaivert.htm	Edgar Link	pending
exhibit1064-amendmentno3to.htm	Edgar Link	pending
exhibit1065-fourteenthamen.htm	Edgar Link	pending
exhibit1066-fifthamendment.htm	Edgar Link	pending
exhibit1067-thirdamendment.htm	Edgar Link	pending
exhibit231consentofpricewa.htm	Edgar Link	pending
exhibit232consentofgrantth.htm	Edgar Link	pending
exhibit311-ye2023.htm	Edgar Link	pending
exhibit312-ye2023.htm	Edgar Link	pending
exhibit321-ye2023.htm	Edgar Link	pending
exhibit322-ye2023.htm	Edgar Link	pending
exhibit97d-wavequantumxcla.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qbts-20231231.htm	Edgar Link	pending
qbts-20231231.xsd	Edgar Link	pending
qbts-20231231_g1.jpg	Edgar Link	pending
qbts-20231231_g2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
qbts-20231231_cal.xml	Edgar Link	unprocessable
qbts-20231231_def.xml	Edgar Link	unprocessable
qbts-20231231_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qbts-20231231_lab.xml	Edgar Link	unprocessable
qbts-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QBTS
D-Wave Quantum Inc. Stock $qbts

2024 Q1 Form 10-K Financial Statement

#000190798224000049 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS D-Wave Quantum Inc. Stock $qbts

2024 Q1 Form 10-K Financial Statement

#000190798224000049 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS
D-Wave Quantum Inc. Stock $qbts